• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒2型疫苗的急性不良事件:德国西北部两家市级医院医护人员疫苗接种活动的经验

Acute adverse events of Sars-CoV2 vaccines: Experiences from a health care worker vaccination campaign in two municipal hospitals in northwest Germany.

作者信息

Kermer Pawel, Abdalla Yasser, Klein Guido, Lüers Claus

机构信息

Nordwest-Krankenhaus Sanderbusch, Friesland Kliniken gGmbH, Sande, Germany.

University Medical Center Göttingen, Germany.

出版信息

Vaccine X. 2023 Apr;13:100257. doi: 10.1016/j.jvacx.2022.100257. Epub 2022 Dec 28.

DOI:10.1016/j.jvacx.2022.100257
PMID:36590445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9794527/
Abstract

Vaccination is considered the best measure to overcome the Sars-Cov2 pandemic. However, changing national recommendations on sequence and time frame necessitate the collection of real-word data on adverse events of Sars-CoV2 vaccination protocols outside of pivotal trials. We report results from a survey on the adverse events and the operational consequences of a Sars-CoV2 vaccination campaign with partly mixed vaccination protocol as well as booster vaccination. While the spectrum of adverse effects in our cohort appeared to be similar to pivotal studies, there were substantial differences in both frequency and distribution with only 3 out of 10 participants staying symptom-free. In over 26% of vaccinees symptoms were so severe, that they stayed at home with mean days on sick leave being 1.5 per person using mixed vaccination protocol. Being aware, that these results might partially be attributable to nocebo effects they are of importance for future vaccination campaigns.

摘要

接种疫苗被认为是战胜新冠疫情的最佳措施。然而,国家关于接种顺序和时间框架的建议不断变化,这就需要收集关键试验之外的新冠疫苗接种方案不良事件的真实数据。我们报告了一项关于新冠疫苗接种活动不良事件及操作后果的调查结果,该接种活动采用了部分混合接种方案以及加强接种。虽然我们队列中的不良反应谱似乎与关键研究相似,但在频率和分布上存在显著差异,10名参与者中只有3人没有症状。超过26%的接种者症状严重,以至于他们居家休息,采用混合接种方案的接种者平均每人病假天数为1.5天。尽管意识到这些结果可能部分归因于反安慰剂效应,但它们对未来的疫苗接种活动具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bb/9841159/710019c80a52/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bb/9841159/079e59882607/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bb/9841159/d9200e8cc784/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bb/9841159/710019c80a52/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bb/9841159/079e59882607/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bb/9841159/d9200e8cc784/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3bb/9841159/710019c80a52/gr3.jpg

相似文献

1
Acute adverse events of Sars-CoV2 vaccines: Experiences from a health care worker vaccination campaign in two municipal hospitals in northwest Germany.新型冠状病毒2型疫苗的急性不良事件:德国西北部两家市级医院医护人员疫苗接种活动的经验
Vaccine X. 2023 Apr;13:100257. doi: 10.1016/j.jvacx.2022.100257. Epub 2022 Dec 28.
2
Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).在事件前疫苗接种计划中使用天花疫苗的建议。免疫实践咨询委员会(ACIP)和医疗保健感染控制实践咨询委员会(HICPAC)的补充建议。
MMWR Recomm Rep. 2003 Apr 4;52(RR-7):1-16.
3
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.疫苗安全数据链接中 COVID-19 疫苗接种后吉兰-巴雷综合征的发生率。
JAMA Netw Open. 2022 Apr 1;5(4):e228879. doi: 10.1001/jamanetworkopen.2022.8879.
4
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.同源加强接种 SARS-CoV-2 重组刺突蛋白疫苗(NVX-CoV2373)的安全性和免疫原性:一项随机、安慰剂对照、2 期临床试验的二次分析。
Lancet Infect Dis. 2022 Nov;22(11):1565-1576. doi: 10.1016/S1473-3099(22)00420-0. Epub 2022 Aug 10.
5
Guillain-Barré Syndrome After Ad26.COV2.S Vaccination.接种 Ad26.COV2.S 后出现格林-巴利综合征。
Am J Case Rep. 2022 Feb 14;23:e935275. doi: 10.12659/AJCR.935275.
6
Health Care Workers' Sick Leave due to COVID-19 Vaccination in Context With SARS-CoV-2 Infection and Quarantine-A Multicenter Cross-Sectional Survey.与严重急性呼吸综合征冠状病毒2感染和隔离相关的医护人员因接种新冠病毒疫苗而请病假的情况——一项多中心横断面调查
Open Forum Infect Dis. 2022 Apr 14;9(7):ofac203. doi: 10.1093/ofid/ofac203. eCollection 2022 Jul.
7
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
8
Adverse events following third dose of mRNA COVID-19 vaccination among nursing home residents who received the primary series.接种 mRNA COVID-19 疫苗后第三针后,养老院居民的不良事件,这些居民接受了基础系列疫苗接种。
J Am Geriatr Soc. 2022 Jun;70(6):1642-1647. doi: 10.1111/jgs.17812. Epub 2022 Apr 27.
9
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.一种雾化型腺病毒 5 型载体新冠疫苗(Ad5-nCoV)在成年人中的安全性、耐受性和免疫原性:一项开放标签、随机 1 期临床试验的初步报告。
Lancet Infect Dis. 2021 Dec;21(12):1654-1664. doi: 10.1016/S1473-3099(21)00396-0. Epub 2021 Jul 26.
10
Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS.与BNT162b2、Ad26.COV2.S和mRNA-1273新冠疫苗相关的严重不良反应:通过疫苗不良事件报告系统(VAERS)深入了解
Front Pharmacol. 2022 Nov 7;13:921760. doi: 10.3389/fphar.2022.921760. eCollection 2022.

引用本文的文献

1
The Global Burden of Absenteeism Related to COVID-19 Vaccine Side Effects Among Healthcare Workers: A Systematic Review and Meta-Analysis.医护人员中与新冠疫苗副作用相关的缺勤全球负担:一项系统评价与荟萃分析
Vaccines (Basel). 2024 Oct 19;12(10):1196. doi: 10.3390/vaccines12101196.

本文引用的文献

1
Safety, immunogenicity & effectiveness of the COVID-19 vaccine among healthcare workers in a tertiary care hospital.COVID-19 疫苗在一家三级医院医护人员中的安全性、免疫原性和有效性。
Indian J Med Res. 2022 May-Jun;155(5&6):518-525. doi: 10.4103/ijmr.ijmr_1771_21.
2
Side effects of the Pfizer BioNTech vaccine in health workers of a hospital in the southeast of Mexico.墨西哥东南部一家医院卫生工作者接种辉瑞疫苗的副作用。
J Infect Dev Ctries. 2022 Sep 30;16(9):1413-1416. doi: 10.3855/jidc.15545.
3
Analysis of Adverse Effects of COVID-19 Vaccines Experienced by Healthcare Workers at Guizhou Provincial Staff Hospital, China.
中国贵州省职工医院医护人员接种新型冠状病毒肺炎疫苗的不良反应分析
Vaccines (Basel). 2022 Sep 2;10(9):1449. doi: 10.3390/vaccines10091449.
4
Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge.2019冠状病毒病疫苗的全球安全性监测:药物警戒如何应对挑战
Ther Adv Drug Saf. 2022 Aug 25;13:20420986221118972. doi: 10.1177/20420986221118972. eCollection 2022.
5
Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine.接种BNT162b2 mRNA新冠疫苗的医护人员不良事件与抗体滴度之间的相关性
Vaccines (Basel). 2022 Jul 30;10(8):1220. doi: 10.3390/vaccines10081220.
6
Adverse events after BNT162b2 mRNA COVID-19 vaccination in health care workers and medical students in Japan.日本医护人员和医学生接种 BNT162b2 mRNA COVID-19 疫苗后的不良事件。
J Infect Chemother. 2022 Aug;28(8):1220-1224. doi: 10.1016/j.jiac.2022.05.002. Epub 2022 May 11.
7
Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis.COVID-19 疫苗试验安慰剂组不良事件的频率:系统评价和荟萃分析。
JAMA Netw Open. 2022 Jan 4;5(1):e2143955. doi: 10.1001/jamanetworkopen.2021.43955.
8
Sick leave request following anti-COVID-19 vaccine administration is low among healthcare workers: results from a retrospective cross-sectional monocentric study.接种新冠疫苗后请病假的医护人员比例较低:一项回顾性横断面单中心研究的结果。
Eur Rev Med Pharmacol Sci. 2021 Dec;25(23):7218-7222. doi: 10.26355/eurrev_202112_27414.
9
Acute unsolicited adverse events following BNT162b2 vaccine in Saudi Arabia, a real-world data.沙特阿拉伯真实世界数据中,BNT162b2 疫苗接种后的急性非预期不良事件。
Vaccine. 2022 Jan 24;40(3):477-482. doi: 10.1016/j.vaccine.2021.12.001. Epub 2021 Dec 13.
10
Correlation of Anti-SARS-CoV-2 S1-specificIgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers.医护人员接种 BNT162b2 mRNA COVID-19 疫苗后抗 SARS-CoV-2 S1 特异性 IgG 抗体水平与不良事件的相关性。
Vaccine. 2022 Jan 24;40(3):428-431. doi: 10.1016/j.vaccine.2021.11.082. Epub 2021 Dec 3.